Biocorrx Inc. (BICX) 0.0438 $BICX
BioCorRx, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
GlobeNewswire - Wed Jul 08, 7:00AM CDT
BioCorRx Inc. (OTCQB:BICX), developer of the Start Fresh Program (R) used for the treatment of alcohol and opioid dependence, today announced that it has retained Maxim Group LLC, a leading investment banking, securities, and investment firm, to provide strategic corporate planning and investment banking services. Maxim will focus on assisting BioCorRx in its strategies for maximizing shareholder value through its full scope of investment banking services.
BioCorRx, Inc. Finalizes Asset Purchase Agreement to Acquire Naltrexone Implant Formula for Treating Addiction
GlobeNewswire - Tue Jul 07, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces the finalization of an asset purchase agreement with Trinity Compound Solutions (formerly Trinity Rx Solutions) ("Trinity"
for its Naltrexone implant formula with an option to purchase other formulas from Trinity. The Company had previously entered into a letter of understanding (LOU) with Trinity for this agreement. This naltrexone pellet formula is used by a select compounding pharmacist trained to make the specific implant used in the Start Fresh Program. The Company currently has exclusive use rights to the implant in the U.S. and abroad (excluding Australia and New Zealand).
BioCorRx, Inc. Announces First Patients Treated in Wellness Center Pilot Using the Start Fresh Program
GlobeNewswire - Mon Jul 06, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces update on the Company's pilot program with Myriad Medical Marketing (MMM). The first location in the pilot program, Corona Physical Medicine (CPM), has just treated their first three patients using the Start Fresh Program. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879.
BioCorRx, Inc. and Sobriety and Addiction Solutions, LLC Announce Mutual Separation; Plan to Advocate for Wider Naltrexone Implant Use in the Treatment of Addiction
GlobeNewswire - Thu Jul 02, 1:55PM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the mutual release of Sobriety and Addiction Solutions, LLC (SAS) from its license agreements with the Company. They were previously offering the Start Fresh Program for locations in Walnut Creek, Fresno and Washington D.C. under MyLife Recovery Centers (MyLife). With different views on how to best approach and capture market share of the $35 billion addiction treatment industry, the companies felt that this separation would allow each party to pursue their respective strategies to help more people suffering from addiction in the largely fragmented addiction treatment market.
BUYINS.NET Updates BioCorRx (BICX) SqueezeTrigger Report
M2 - Wed Jun 10, 8:56AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on BioCorRx (OTC: BICX) after releasing the latest short sale data through June 9, 2015. The total aggregate number of shares shorted since August 2010 is approximately 55.6 million shares. Approximately 24.95% of daily trading volume is short selling. The SqueezeTrigger price for all BICX shares shorted is $0.22. A short squeeze is expected to begin when shares of BICX close above the $0.22 SqueezeTrigger price.
BioCorRx Inc. Reports First Quarter 2015 Financial Results
GlobeNewswire - Wed May 20, 2:08PM CDT
BioCorRx Inc. Reports First Quarter 2015 Financial Results
BioCorRx, Inc. and Start Fresh Featured on MSNBC, SAMHSA and NIAAA Endorse Medication for Treatment of Alcohol Abuse Disorders
GlobeNewswire - Tue Apr 28, 7:00AM CDT
BioCorRx, Inc. (BICX) announces MSNBC segment featuring Brady Granier, COO and interim CEO, alongside Start Fresh Program and Growing Pains alum, Jeremy Miller. The two were interviewed by Tamron Hall of NewsNation to discuss Jeremy's success with the Start Fresh Program, a medication-assisted treatment program developed by BioCorRx that is used to treat alcohol and opioid addiction. The MSNBC segment originally aired on April 21, 2015 and can be viewed online here.
BioCorRx, Inc. Announces Start Date of Start Fresh Program(r) Pilot at Wellness Center in Corona, CA
GlobeNewswire - Tue Apr 14, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the Company's pilot program that was created as a result of an agreement with Myriad Medical Marketing (MMM) is scheduled to launch later this month. As of April 27, 2015 Corona Physical Medicine (CPM) in Corona, CA plans to begin setting appointments with potential patients. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide.
BioCorRx, Inc. Reports 2014 Financial Results
GlobeNewswire - Thu Apr 02, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces its 2014 Financial Results with highlights as follows:
Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.
PR Newswire - Fri Mar 27, 5:23PM CDT
BioCorRx, Inc. (BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S. alone. The Company created a unique treatment program which includes the use of FDA-approved Naltrexone in a specially compounded form for outpatient surgical implantation. The Company has exclusive rights (excluding Australia and New Zealand) to the specially formulated Naltrexone implant. The treatment program also includes an outpatient coaching regimen in which patients receive psycho-social therapy and support for their alcohol or substance abuse addictions.
/DISREGARD RELEASE: Small Cap IR/
PR Newswire - Fri Mar 27, 10:12AM CDT
We are advised by Small Cap IR that journalists and other readers should disregard the news release, BioCorRX Inc. Positions Itself Through New Acquisitions, And Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.: Analyst Report Issued by Small Cap IR, issued 27-Mar-2015 over PR Newswire. A corrected release will be issed later today.
BioCorRX Inc. Positions Itself Through New Acquisitions, And Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.: Analyst Report Issued by Small Cap IR
PR Newswire - Fri Mar 27, 6:00AM CDT
BioCorRx, Inc. (OTCBB: BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S. alone. The Company utilizes a unique treatment regiment through the use of FDA-approved Naltrexone, which the Company has exclusive rights to (excluding Australia and New Zealand). This program is also supplemented with heavy life coaching in which patients receive further treatment for their alcohol or substance abuse addictions.
Brady Granier, Chief Operating Officer and Interim Chief Executive Officer of BioCorRx, Inc., Discusses Recent News in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Thu Mar 26, 7:00AM CDT
SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTC QB:BICX), developer of the Start Fresh Program, is now available. The interview can be heard at http://smallcapvoice.com/blog/3-24-15-smallca...x-inc-bicx.
BioCorRx, Inc. Enters Definitive Agreement with Myriad Medical Marketing to Introduce Start Fresh Program to Wellness Centers
GlobeNewswire - Wed Mar 25, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the execution of a definitive agreement with Myriad Medical Marketing (MMM). The Company had previously announced the letter of intent to enter into an agreement with MMM back on February 27, 2015. As a result of the agreement, MMM will become the exclusive sales agent for BioCorRx within the Wellness Center category across the United States with the exception of licensee owned territories. The Company also recently announced a supply and distribution agreement with the first wellness center in Corona, CA for a pilot program. Four other wellness centers are planned to be a part of the pilot program. Upon the successful completion of the pilot program, MMM will introduce the Start Fresh Program into Physicians Business Solutions (PBS). PBS provides medical services and alternative revenue options to a network of 1000 medical centers nationwide. "Things are progressing nicely with this new endeavor. Now that we have the definitive agreement in place and a supply agreement with the first wellness center, we can focus on getting the pilot going," stated COO & interim CEO, Brady Granier.
Wealthmakers.com Initiates Coverage on BioCorRx (BICX)
GlobeNewswire - Mon Mar 23, 7:30AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announced today that WEALTHMAKERS.COM www.wealthmakers.com, a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals, and public company employees to make precise, predictive, and profitable trading decisions, has initiated coverage on BioCorRx (OTC: BICX). The report from Wealthmakers.com highlights a possible short term bullish pattern that has emerged and a SqueezeTrigger Price of $.225. Details about both and more can be found in the report immediately below.
BioCorRx (BICX) is Undervalued With Short Term Bullish Patterns
M2 - Mon Mar 23, 6:50AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has updated its research report today on BioCorRx (OTC: BICX). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $.225 and the projected short squeeze valuation of $1.38 per share.
BioCorRx, Inc. Announces Reinstatement of Letter of Understanding to Acquire Naltrexone Implant Formula for Treating Addiction
GlobeNewswire - Wed Mar 18, 7:09AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces the reinstatement of the letter of understanding (LOU) to acquire Trinity Rx Solutions and all of its formulas. The list of formulas includes the naltrexone pellet formula that is used to make the implant for which the Company currently has exclusive use rights in the U.S. and abroad (excluding Australia and New Zealand). The LOU has been reinstated with the understanding that the parties will close on a definitive agreement by the end of the year.
BioCorRx, Inc. Enters into Supply Agreement to Distribute Start Fresh Program(r) through Established Wellness Center in Corona, CA
GlobeNewswire - Thu Mar 12, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the program will soon be offered in an existing wellness center in Corona, CA through a recently executed supply and distribution agreement with Corona Physical Medicine (CPM). This new relationship is a result of the company's recent letter of intent with Myriad Medical Marketing (MMM) to begin a pilot program for the Start Fresh Program within existing wellness centers. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon a successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide. "It's great to finally be growing our footprint in Southern California and we are looking forward to getting this pilot started here. We believe that the implementation of the program into an existing wellness center with an established patient base will help spread program awareness and help those battling addiction in the Inland Empire area of Southern California," stated COO & interim CEO, Brady Granier.
BioCorRx, Inc. and MyLife Recovery CentersTM Announce Availability of the Start Fresh Program(r) for Treating Addiction in Washington, D.C.
GlobeNewswire - Mon Mar 09, 6:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the opening of a new center offering the program in Washington D.C. by its licensee, Sobriety and Addiction Solutions, LLC (SAS). SAS operates as MyLife Recovery Centers and has two other locations in California: Walnut Creek and Fresno. BioCorRx, Inc. is pleased to continue on its trajectory of expansion through Q1 2015. A clinic serving the nation's capital and surrounding areas is another step forward in broadening the accessibility of the Start Fresh Program nationally," stated COO & interim CEO, Brady Granier. The center is to be located at 3 Washington Circle NW, Washington, D.C. 20037. The clinic plans to officially open on March 12, 2015 and is currently scheduling patient consultations. With the opening of this new location, there will be a total of 13 centers across the United States offering the Start Fresh Program, more than double the number of centers as compared to approximately 5 months ago.
BioCorRx, Inc. Announces Availability of its Start Fresh Program(r) for Treating Addiction in West Hartford, Connecticut
GlobeNewswire - Tue Feb 03, 7:00AM CST
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the opening of a new Start Fresh Recovery center in West Hartford, CT. The center will operate under a distribution arrangement with JPL, LLC. JPL holds the distribution rights to the Start Fresh Program for the state of Connecticut. This is their second opening in the state. Their other location is located in Norwalk. "BioCorRx, Inc. is pleased with the back-to-back openings of two new centers at the start of 2015, especially since one of them is a second opening by one of our licensees," stated COO & interim CEO, Brady Granier. Last week the company announced a new center will soon be open in the Dallas metropolitan area. "An additional center in the Northeast is a significant step towards broadening the accessibility of the Start Fresh program", says Mr. Granier. The center is located at 970 Farmington Ave., Suite 304, West Hartford, CT 06107. It will officially open on February 9, 2015. With the opening of this new location, there will now be a total of 12 centers across the United States offering the Start Fresh Program.
BioCorRx, Inc. Announces Engagement of Maxim Group LLC to Provide Strategic Advisory Services
GlobeNewswire - Wed Jul 08, 7:00AM CDT
BioCorRx Inc. (OTCQB:BICX), developer of the Start Fresh Program (R) used for the treatment of alcohol and opioid dependence, today announced that it has retained Maxim Group LLC, a leading investment banking, securities, and investment firm, to provide strategic corporate planning and investment banking services. Maxim will focus on assisting BioCorRx in its strategies for maximizing shareholder value through its full scope of investment banking services.
BioCorRx, Inc. Finalizes Asset Purchase Agreement to Acquire Naltrexone Implant Formula for Treating Addiction
GlobeNewswire - Tue Jul 07, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces the finalization of an asset purchase agreement with Trinity Compound Solutions (formerly Trinity Rx Solutions) ("Trinity"
for its Naltrexone implant formula with an option to purchase other formulas from Trinity. The Company had previously entered into a letter of understanding (LOU) with Trinity for this agreement. This naltrexone pellet formula is used by a select compounding pharmacist trained to make the specific implant used in the Start Fresh Program. The Company currently has exclusive use rights to the implant in the U.S. and abroad (excluding Australia and New Zealand). BioCorRx, Inc. Announces First Patients Treated in Wellness Center Pilot Using the Start Fresh Program
GlobeNewswire - Mon Jul 06, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces update on the Company's pilot program with Myriad Medical Marketing (MMM). The first location in the pilot program, Corona Physical Medicine (CPM), has just treated their first three patients using the Start Fresh Program. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879.
BioCorRx, Inc. and Sobriety and Addiction Solutions, LLC Announce Mutual Separation; Plan to Advocate for Wider Naltrexone Implant Use in the Treatment of Addiction
GlobeNewswire - Thu Jul 02, 1:55PM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the mutual release of Sobriety and Addiction Solutions, LLC (SAS) from its license agreements with the Company. They were previously offering the Start Fresh Program for locations in Walnut Creek, Fresno and Washington D.C. under MyLife Recovery Centers (MyLife). With different views on how to best approach and capture market share of the $35 billion addiction treatment industry, the companies felt that this separation would allow each party to pursue their respective strategies to help more people suffering from addiction in the largely fragmented addiction treatment market.
BUYINS.NET Updates BioCorRx (BICX) SqueezeTrigger Report
M2 - Wed Jun 10, 8:56AM CDT
BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has updated coverage on BioCorRx (OTC: BICX) after releasing the latest short sale data through June 9, 2015. The total aggregate number of shares shorted since August 2010 is approximately 55.6 million shares. Approximately 24.95% of daily trading volume is short selling. The SqueezeTrigger price for all BICX shares shorted is $0.22. A short squeeze is expected to begin when shares of BICX close above the $0.22 SqueezeTrigger price.
BioCorRx Inc. Reports First Quarter 2015 Financial Results
GlobeNewswire - Wed May 20, 2:08PM CDT
BioCorRx Inc. Reports First Quarter 2015 Financial Results
BioCorRx, Inc. and Start Fresh Featured on MSNBC, SAMHSA and NIAAA Endorse Medication for Treatment of Alcohol Abuse Disorders
GlobeNewswire - Tue Apr 28, 7:00AM CDT
BioCorRx, Inc. (BICX) announces MSNBC segment featuring Brady Granier, COO and interim CEO, alongside Start Fresh Program and Growing Pains alum, Jeremy Miller. The two were interviewed by Tamron Hall of NewsNation to discuss Jeremy's success with the Start Fresh Program, a medication-assisted treatment program developed by BioCorRx that is used to treat alcohol and opioid addiction. The MSNBC segment originally aired on April 21, 2015 and can be viewed online here.
BioCorRx, Inc. Announces Start Date of Start Fresh Program(r) Pilot at Wellness Center in Corona, CA
GlobeNewswire - Tue Apr 14, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the Company's pilot program that was created as a result of an agreement with Myriad Medical Marketing (MMM) is scheduled to launch later this month. As of April 27, 2015 Corona Physical Medicine (CPM) in Corona, CA plans to begin setting appointments with potential patients. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide.
BioCorRx, Inc. Reports 2014 Financial Results
GlobeNewswire - Thu Apr 02, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces its 2014 Financial Results with highlights as follows:
Small Cap IR Correction -- BioCorRx Inc. Positions Itself Through Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.
PR Newswire - Fri Mar 27, 5:23PM CDT
BioCorRx, Inc. (BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S. alone. The Company created a unique treatment program which includes the use of FDA-approved Naltrexone in a specially compounded form for outpatient surgical implantation. The Company has exclusive rights (excluding Australia and New Zealand) to the specially formulated Naltrexone implant. The treatment program also includes an outpatient coaching regimen in which patients receive psycho-social therapy and support for their alcohol or substance abuse addictions.
/DISREGARD RELEASE: Small Cap IR/
PR Newswire - Fri Mar 27, 10:12AM CDT
We are advised by Small Cap IR that journalists and other readers should disregard the news release, BioCorRX Inc. Positions Itself Through New Acquisitions, And Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.: Analyst Report Issued by Small Cap IR, issued 27-Mar-2015 over PR Newswire. A corrected release will be issed later today.
BioCorRX Inc. Positions Itself Through New Acquisitions, And Strategic Partnerships To Gain Market Share Of The $22 Billion Substance Abuse Treatment Market In The U.S.: Analyst Report Issued by Small Cap IR
PR Newswire - Fri Mar 27, 6:00AM CDT
BioCorRx, Inc. (OTCBB: BICX) operating in Santa Ana, California is a healthcare solutions organization, which focuses solely on addiction treatment; the market for which is estimated at $22 billion in the U.S. alone. The Company utilizes a unique treatment regiment through the use of FDA-approved Naltrexone, which the Company has exclusive rights to (excluding Australia and New Zealand). This program is also supplemented with heavy life coaching in which patients receive further treatment for their alcohol or substance abuse addictions.
Brady Granier, Chief Operating Officer and Interim Chief Executive Officer of BioCorRx, Inc., Discusses Recent News in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Thu Mar 26, 7:00AM CDT
SmallCapVoice.com, Inc. (SCV) announced today that a new audio interview with BioCorRx, Inc. (OTC QB:BICX), developer of the Start Fresh Program, is now available. The interview can be heard at http://smallcapvoice.com/blog/3-24-15-smallca...x-inc-bicx.
BioCorRx, Inc. Enters Definitive Agreement with Myriad Medical Marketing to Introduce Start Fresh Program to Wellness Centers
GlobeNewswire - Wed Mar 25, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the execution of a definitive agreement with Myriad Medical Marketing (MMM). The Company had previously announced the letter of intent to enter into an agreement with MMM back on February 27, 2015. As a result of the agreement, MMM will become the exclusive sales agent for BioCorRx within the Wellness Center category across the United States with the exception of licensee owned territories. The Company also recently announced a supply and distribution agreement with the first wellness center in Corona, CA for a pilot program. Four other wellness centers are planned to be a part of the pilot program. Upon the successful completion of the pilot program, MMM will introduce the Start Fresh Program into Physicians Business Solutions (PBS). PBS provides medical services and alternative revenue options to a network of 1000 medical centers nationwide. "Things are progressing nicely with this new endeavor. Now that we have the definitive agreement in place and a supply agreement with the first wellness center, we can focus on getting the pilot going," stated COO & interim CEO, Brady Granier.
Wealthmakers.com Initiates Coverage on BioCorRx (BICX)
GlobeNewswire - Mon Mar 23, 7:30AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announced today that WEALTHMAKERS.COM www.wealthmakers.com, a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals, and public company employees to make precise, predictive, and profitable trading decisions, has initiated coverage on BioCorRx (OTC: BICX). The report from Wealthmakers.com highlights a possible short term bullish pattern that has emerged and a SqueezeTrigger Price of $.225. Details about both and more can be found in the report immediately below.
BioCorRx (BICX) is Undervalued With Short Term Bullish Patterns
M2 - Mon Mar 23, 6:50AM CDT
WEALTHMAKERS.COM / www.wealthmakers.com , a Wall Street research and trading firm providing unbiased statistical stock market predictions to empower investors, securities professionals and public company employees to make precise, predictive and profitable trading decisions, has updated its research report today on BioCorRx (OTC: BICX). The report highlights the short term bullish pattern that has emerged, the SqueezeTrigger Price of $.225 and the projected short squeeze valuation of $1.38 per share.
BioCorRx, Inc. Announces Reinstatement of Letter of Understanding to Acquire Naltrexone Implant Formula for Treating Addiction
GlobeNewswire - Wed Mar 18, 7:09AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program(R) used for the treatment of alcohol and opioid dependence, announces the reinstatement of the letter of understanding (LOU) to acquire Trinity Rx Solutions and all of its formulas. The list of formulas includes the naltrexone pellet formula that is used to make the implant for which the Company currently has exclusive use rights in the U.S. and abroad (excluding Australia and New Zealand). The LOU has been reinstated with the understanding that the parties will close on a definitive agreement by the end of the year.
BioCorRx, Inc. Enters into Supply Agreement to Distribute Start Fresh Program(r) through Established Wellness Center in Corona, CA
GlobeNewswire - Thu Mar 12, 7:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces that the program will soon be offered in an existing wellness center in Corona, CA through a recently executed supply and distribution agreement with Corona Physical Medicine (CPM). This new relationship is a result of the company's recent letter of intent with Myriad Medical Marketing (MMM) to begin a pilot program for the Start Fresh Program within existing wellness centers. CPM is located at 1150 El Camino Avenue, Suite 108, Corona, CA 92879. This will be the first of five planned locations to participate in the Start Fresh pilot program. Upon a successful completion of the pilot program, MMM will begin to introduce the Start Fresh Program to other wellness centers nationwide. "It's great to finally be growing our footprint in Southern California and we are looking forward to getting this pilot started here. We believe that the implementation of the program into an existing wellness center with an established patient base will help spread program awareness and help those battling addiction in the Inland Empire area of Southern California," stated COO & interim CEO, Brady Granier.
BioCorRx, Inc. and MyLife Recovery CentersTM Announce Availability of the Start Fresh Program(r) for Treating Addiction in Washington, D.C.
GlobeNewswire - Mon Mar 09, 6:00AM CDT
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the opening of a new center offering the program in Washington D.C. by its licensee, Sobriety and Addiction Solutions, LLC (SAS). SAS operates as MyLife Recovery Centers and has two other locations in California: Walnut Creek and Fresno. BioCorRx, Inc. is pleased to continue on its trajectory of expansion through Q1 2015. A clinic serving the nation's capital and surrounding areas is another step forward in broadening the accessibility of the Start Fresh Program nationally," stated COO & interim CEO, Brady Granier. The center is to be located at 3 Washington Circle NW, Washington, D.C. 20037. The clinic plans to officially open on March 12, 2015 and is currently scheduling patient consultations. With the opening of this new location, there will be a total of 13 centers across the United States offering the Start Fresh Program, more than double the number of centers as compared to approximately 5 months ago.
BioCorRx, Inc. Announces Availability of its Start Fresh Program(r) for Treating Addiction in West Hartford, Connecticut
GlobeNewswire - Tue Feb 03, 7:00AM CST
BioCorRx, Inc. (BICX), developer of the Start Fresh Program, announces the opening of a new Start Fresh Recovery center in West Hartford, CT. The center will operate under a distribution arrangement with JPL, LLC. JPL holds the distribution rights to the Start Fresh Program for the state of Connecticut. This is their second opening in the state. Their other location is located in Norwalk. "BioCorRx, Inc. is pleased with the back-to-back openings of two new centers at the start of 2015, especially since one of them is a second opening by one of our licensees," stated COO & interim CEO, Brady Granier. Last week the company announced a new center will soon be open in the Dallas metropolitan area. "An additional center in the Northeast is a significant step towards broadening the accessibility of the Start Fresh program", says Mr. Granier. The center is located at 970 Farmington Ave., Suite 304, West Hartford, CT 06107. It will officially open on February 9, 2015. With the opening of this new location, there will now be a total of 12 centers across the United States offering the Start Fresh Program.
